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Bronchial asthmaAbstract Background: Asthma is one of the most common chronic diseases worldwide and has
been increasing in prevalence over the last few decades; its exact cause remains unknown and likely
has its origin in complex interactions among multiple genetic and environmental factors. TheWorld
Health Organization (WHO) stated that approximately 300 million people have asthma. Recently
the effects of vitamin D as a hormone have gained attention. Vitamin D appears to have regulatory
effects on every part of the immune system, vitamin D deﬁciency being linked to an array of immu-
nologically based diseases focusing on asthma. So the assessment of serum vitamin D in patients
with bronchial asthma is useful.
Objective: The aim of this study is to assess the level of serum vitamin D in patients with bron-
chial asthma.
Methods: The present study, included 50 subjects, 40 patients diagnosed as bronchial asthma
and 10 healthy volunteers. The asthmatic patient group was divided into group (A) asthma in
between attack and group (B) exacerbated asthma, that was divided into subgroups (I), (II) and
(III) mild, moderate and severe exacerbated asthma, respectively according to severity of symptoms
and FEV1.
Results: Serum vitamin D level was highly signiﬁcantly lower in the asthmatic patient group
compared to the control subject group and lowest serum 25 hydroxy(OH) vitamin D value in the
severely exacerbated asthma group. There was a positive correlation between decreased serum 25
(OH)D levels and decreased FEV1.
Conclusions: Vitamin D deﬁciency was highly prevalent in asthmatic patients, there was a strong
correlation between asthma severity and 25(OH) vitamin D concentrations and there was a directd.
2 H.E. Abd El Aaty et al.and a positive signiﬁcant correlation between vitamin D levels and pulmonary function tests in asth-
matic patients, so the measurement of serum vitamin D levels in patients with bronchial asthma is
very useful.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Asthma is a heterogeneous disease, usually characterized by
chronic airway inﬂammation. It is deﬁned by the history of
respiratory symptoms such as wheeze, shortness of breath,
chest tightness and cough that vary over time and in intensity,
together with variable expiratory airﬂow limitation [1]. As of
2011, 235–330 million people worldwide were affected by
asthma [2].
Vitamin D is a fat-soluble nutrient and a secosteroid hor-
mone which is widely recognized as a modulator of calcium
absorption and bone health and further regulates neuromuscu-
lar function, cellular differentiation, insulin secretion and
blood pressure [3].
Vitamin D has been shown to have a role in both innate
and adaptive immunity by promoting phagocytosis and mod-
ulating the effects of Th1, Th2 and regulatory T cells [4,5].
Further evidence suggests that vitamin D alters human airway
smooth muscle expression of chemokines and inhibits the
expression of a steroid resistant gene [6]. It has been demon-
strated that insufﬁcient vitamin D levels (deﬁned by serum
concentrations <30 ng/mL) were associated with an increased
risk of severe asthma during childhood [7]. Vitamin D deﬁ-
ciency has been associated with increased airway hyperrespon-
siveness (AWH), lower pulmonary function, worse asthma
control and steroid resistance [8].Patients and methods
Study design
Our study included 50 subjects chosen randomly from patients
who attended the chest out clinic and admitted at the chest
department of the Menouﬁa University Hospital during acute
exacerbation between September 2013 and March 2014, their
ages ranged from 19 to 58 y with a mean age of 39.72 ± 9.6 y.
They were divided into two groups: Control group: 10 matched
healthy individuals, their ages ranged from 19 to 45 y with a
mean age of 38.3 ± 8.3 y and Asthmatic patient group: 40
patients with bronchial asthma, their ages ranged from 23 to
58 y with a mean age of 41.2 ± 9.46 y, It was divided into
two groups: Group (A): 20 patients with bronchial asthma in
between attack (not in exacerbation), their ages ranged from
23 to 58 y with a mean age of 40.75 ± 10.7 y. Group (B): 20
patients with exacerbation of bronchial asthma, their ages ran-
ged from 30 to 58 y with a mean age of 41.65 ± 8.3 y, it was
divided into three subgroups according to severity of symptoms
and FEV1 [1].
Subgroup B (I): 4 patients with mild exacerbation
(FEV1P80% predicted) of bronchial asthma, their ages ran-
ged from 34 to 44 y with a mean age of 38 ± 43 y. Subgroup
B (II): 6 patients with moderate exacerbation of bronchialasthma (FEV1 60–80% predicted) their ages ranged from 36
to 55 y with a mean age of 43.5 ± 7.97 y. Subgroup B (III):
10 patients with severe exacerbation of bronchial asthma
(FEV1 660% predicted), their ages ranged from 30 to 58 y
with a mean age of 42 ± 9.79 y.
Exclusion criteria of the study: Patients <18 year, Patients
with renal or liver diseases, Patients with D.M. or Pregnant
females.
In this study all subjects were subjected to the following:
Full history taking, Full clinical examination (general and
local), Plain CXR (postero-anterior view), CBC, Liver
function tests, Kidney function tests, Random blood sugar,
Pulmonary function tests (before and after bronchodilators)
and Assay of serum vitamin D levels by ELISA [9].
Statistical analysis [10]
Data collected were tabulated and analyzed by SPSS (statisti-
cal package for the social science software) statistical package
version 16 on an IBM compatible computer.
Quantitative data were expressed as mean and standard
deviation (X + SD) and analyzed by applying student t-test
for comparison of two groups of normally distributed
variables.
Qualitative data were expressed as number and percentage
(No & %) and analyzed by applying chi-square test.
All these tests were used as tests of signiﬁcance at P< 0.05.
Results
In this work, 40 adult asthmatic patients and 10 healthy volun-
teers were included. The asthmatic patients were grouped as
follows: group (A) asthma in between attack and group (B)
exacerbated asthma, that was divided into subgroups (I), (II)
and (III) mild, moderate and severe exacerbated asthma
respectively (Tables 1–6 and Figs. 1 and 2).Discussion
Asthma is a common chronic inﬂammatory condition of the
airways. As a result of the airway inﬂammation, the bronchi
are hyperactive and narrow in response to a wide range of
stimuli, initially reversible. The inﬂammation may lead to
irreversible obstruction to airﬂow. Asthma results from the
interaction of many genetic and environmental factors which
inﬂuence the tone or reactivity of the airways, the response
varies from individual to individual and from time to time [11].
Vitamin D deﬁciency is linked to an array of immunologi-
cally based diseases focusing on asthma. Because vitamin D
promotes steroid sensitivity in the body, can down regulate
an inﬂammatory state via gene expression and cytokines
production, its action in this case could be directly on the
Table 1 Comparison between demographic data (age, sex, smoking status and B.M.I.) among the studied groups.
Groups X2 P value
Control group Asthma in between attack group(A) Exacerbated asthma group(B)
No % No % No %
Sex Male 3 30 6 30 6 30 0 >0.05
Female 7 70 14 70 14 70
Smoking status Yes 0 0 4 20 4 20 0 >0.05
No 10 100 16 80 16 80
Age Mean ± SD 38.3 ± 8.3 40.75 ± 10.7 41.65 ± 8.3 2.6 >0.05
B.M.I. Mean ± SD 24.5 ± 3.01 24.15 ± 2.9 25.85 ± 2.7 1.9 >0.05
P> 0.05 non-signiﬁcant relation.*P< 0.05 signiﬁcant relation.**P< 0.01 highly signiﬁcant relation.
This table shows that there was non signiﬁcant relation between the studied groups.
Table 5 Comparison between serum vitamin D levels among mild, moderate, severe exacerbated asthma subgroups B (I), (II)and
(III).
Exacerbated asthma groups (B) Serum Vit. D Level
Mean SD F test P value
Mild (I) N = 4 29.1225 1.08788 38.3** <0.01
P1 < 0.01
P2 < 0.01
P3 < 0.01
Moderate (II) N = 6 22.4767 1.62514
Severe (III) N = 10 17.2890 2.88888
P1 mild regards moderate exacerbated asthma subgroup.
P2 mild regards severe exacerbated asthma subgroup.
P3 moderate regards severe exacerbated asthma subgroup.This table shows that, serum vitamin D is highly signiﬁcantly lower.
In moderate exacerbated asthma subgroup B compared to mild and severe compared to mild and moderate, (P value < 0.01).
**P< 0.01 highly signiﬁcant relation.
Table 2 Comparison between serum vitamin D levels between control group and asthmatic patient group.
Control group N= 10 Asthmatic patient group N= 40 T test P value
Serum Vit. D Level 41.16 ± 5.51 25.43 ± 5.9 7.6** <0.01
This table shows that, serum vitamin D level is highly signiﬁcantly lower in the asthmatic patient group compared to the control group (P
value < 0.01).
**P< 0.01 highly signiﬁcant relation.
Table 3 Comparison between serum vitamin D levels between control group and exacerbated asthma group (B).
Groups Serum Vit. D Level
Mean SD T test P value
Control group N= 10 41.1610 5.51321 9.8** <0.01
Exacerbated asthma group (B) N= 20 21.2120 5.15888
This table shows that, serum vitamin D level is highly signiﬁcantly lower in the exacerbated asthma group (B) compared to the control group (P
value < 0.01).
**P< 0.01 highly signiﬁcant relation.
Table 4 Comparison between serum vitamin D levels between asthma in between attack group (A) and exacerbated asthma group
(B).
Groups Serum Vit. D Level
Mean SD T test P value
Asthma in between attack group (A) N= 20 29.6600 2.74135 6.5** <0.01
Exacerbated asthma group (B) N= 20 21.2120 5.15888
This table shows that, serum vitamin D is highly signiﬁcantly lower in the exacerbated asthma group (B) compared to asthma in between attack
group (A) (P value < 0.01).
**P< 0.01 highly signiﬁcant relation.
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Figure 1 Comparison between serum vitamin D level among
mild, moderate, severe exacerbated asthma subgroups B (I), (II)
and (III).
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Figure 2 Correlation between serum vitamin D level and
FEV1% of predicted among mild, moderate, severe exacerbated
asthma subgroups B (I), (II) and (III).
Table 6 Correlation between serum vitamin D level and FEV1% of predicted among mild, moderate, severe exacerbated asthma
subgroups B (I), (II) and (III).
Exacerbated asthma groups (B) FEV1.% (Pre) Serum Vit. D Level
r P. value
Mild (I) 0.96 (*) <0.05
Moderate (II) 0.924 (**) <0.01
Severe (III) 0.836 (**) <0.01
This table shows that, a signiﬁcant positive correlation between serum vitamin D levels and FEV1% of predicted in Mild exacerbated asthma
subgroup B (I) (P value < 0.05) and highly signiﬁcant positive correlation in moderate and severe exacerbated asthma subgroups B (II) and (III)
(P value < 0.01).
* P< 0.05 signiﬁcant relation.
** P< 0.01 highly signiﬁcant relation.
4 H.E. Abd El Aaty et al.airway. Deﬁciency of Vitamin D could be associated with an
inability to switch off the inﬂammatory state, following an
acute inhalational insult, with up regulation of prostaglandin,
leukotrienes, macrophages, T cell activity and recruitment
[12,13].The study included 50 subjects, 40 patients were diagnosed
with bronchial asthma and 10 healthy volunteers. The asth-
matic patient group was divided into group (A) asthma in
between attack and group (B) exacerbated asthma, that was
divided into subgroups (I), (II) and (III) mild, moderate and
severe exacerbated asthma respectively according to severity
of symptoms and FEV1.
The results of our study show that the serum vitamin D
level is highly signiﬁcantly lower in the asthmatic patient group
compared to the control subject group and the lowest value of
serum 25 hydroxy(OH) D in the severely exacerbated asthma
group. We explained that, vitamin D deﬁciency could be
involved in asthma pathogenesis through several mechanisms.
Vitamin D appears to have regulatory effects on every part of
the immune system, with vitamin D deﬁciency linked to an
array of immunologically based diseases. Because vitamin D
promotes steroid sensitivity in the body and can down regulate
an inﬂammatory state via gene expression and cytokine pro-
duction deﬁciency of vitamin D could be associated with an
inability to switch off the inﬂammatory state [14].
Li. et al. [15] conducted a study on 435 adults with asthma
and reported that, the concentration of 25(OH)D was low in
asthmatic patients.
Also Shaaban and Hashem [16] investigated serum vitamin
D levels in 75 adults with asthma and 75 adult healthy controls
and demonstrated that, vitamin D deﬁciency was observed in
78.66% asthmatic patients whereas 85% of healthy control
subjects expressed sufﬁcient levels.
This study is also in agreement with that of Eman Shebl
et al. [17] who conducted a study on 66 nonsmoking adult
asthmatic patients and 30 healthy adult controls and found
that 40% asthmatic patients suffered from vitamin D insufﬁ-
ciency while in the control group vitamin D insufﬁciency was
present in 20% of them with a signiﬁcant increase in the num-
ber of severe asthmatic patients with vitamin D insufﬁciency
compared with those with sufﬁcient vitamin D.
Also Stephanie Korn et al. [18] studied serum vitamin D
levels in 280 adults with asthma and found that, 25(OH)D con-
centrations in adult asthmatics were low and vitamin D insuf-
ﬁciency or deﬁciency was signiﬁcantly related to asthma
severity.
Similarly Montero Arias et al. [19] demonstrated that,
serum vitamin D levels were examined in 121 adults with
asthma and noted that, in asthmatic patients with low vitamin
D levels there was a signiﬁcant association between vitamin D
levels and the risk of severe asthma, the risk of hospitalization
or visit to the emergency department due to asthma.
Serum Vitamin D in Patients with Bronchial Asthma 5The results of our study show that there was a positive cor-
relation between decreased serum 25 (OH)D concentrations
and decreased FEV1. We explained through the ﬁnding that
vitamin D inhibits the formation of matrix metalloproteinase
as well as ﬁbroblast proliferation and inﬂuences collagen syn-
thesis. These actions mean that 1, 25(OH)2D may inﬂuence tis-
sue remodeling and probably lung function [20].
Shaaban and Hashem [16] demonstrated that, there was a
signiﬁcant association between higher serum vitamin D con-
centration and better lung function.
Also Stephanie Korn et al. [18] reported that, 25(OH)D lev-
els were positively correlated with FEV1.
This study is also in agreement with that of Eman Shebl
et al. [17] who noted that, there was a positive correlation
between 25(OH) D levels and FEV1%.
Conclusion
Vitamin D deﬁciency was highly prevalent in asthmatic
patients, there was a strong correlation between asthma sever-
ity and 25(OH) vitamin D concentrations and there was a
direct and signiﬁcant relationship between vitamin D levels
and pulmonary function tests in asthmatic patients, so the
measurement of serum vitamin D levels in patients with bron-
chial asthma is very useful.
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